A large majority of current smokers using ENDS/ENNDS use products containing nicotine, whereas over a third of never smokers using these devices also use nicotine, highlighting the need to account for nicotine content in population health assessments.
No takes yet. Share an insight, caveat, or question.
Alerts clinicians to prevalent nicotine exposure via ENDS in smokers; leaves open questions on cardiovascular and fetal risks.
Weaver et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: